Plus Therapeutics, Inc. (PSTV) Earnings History
Annual and quarterly earnings data from 1998 to 2025
Loading earnings history...
PSTV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PSTV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 91.5% | -293.5% | -429.4% |
| 2024 | 85.4% | -252.3% | -222.8% |
| 2023 | -97.2% | -271.1% | -271.0% |
| 2022 | -217.9% | -8800.0% | -9051.3% |
| 2021 | - | - | - |
Download Data
Export PSTV earnings history in CSV or JSON format
Free sign-in required to download data
Plus Therapeutics, Inc. (PSTV) Earnings Overview
As of May 8, 2026, Plus Therapeutics, Inc. (PSTV) reported trailing twelve-month net income of -$22M, reflecting +100.0% year-over-year growth. The company earned $-7.19 per diluted share over the past four quarters, with a net profit margin of -429.4%.
Looking at the long-term picture, PSTV's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 1998.
Plus Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NRXP (-$38M net income, -2336.5% margin), AGEN ($115,000 net income, 0.1% margin), CLDX (-$259M net income, -17253.3% margin), PSTV has outperformed on profitability metrics. Compare PSTV vs NRXP →
PSTV Earnings vs Peers
Earnings metrics vs comparable public companies
PSTV Historical Earnings Data (1998–2025)
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$22M | -72.5% | -$15M | $-7.19 | -429.4% | -293.5% |
| 2024 | -$13M | +2.5% | -$15M | $-58500.00 | -222.8% | -252.3% |
| 2023 | -$13M | +34.3% | -$13M | $-106000.00 | -271.0% | -271.1% |
| 2022 | -$20M | -51.3% | -$20M | $-288750.00 | -9051.3% | -8800.0% |
| 2021 | -$13M | -62.6% | -$12M | $-444500.00 | - | - |
| 2020 | -$8M | +24.3% | -$10M | $-697500.00 | -2719.8% | -3163.0% |
| 2019 | -$11M | +13.8% | -$4M | $-999999.00 | -155.6% | -52.3% |
| 2018 | -$13M | +44.3% | -$9M | $-999999.00 | -423.5% | -293.7% |
| 2017 | -$23M | -2.9% | -$21M | $-999999.00 | -353.9% | -322.6% |
| 2016 | -$22M | -17.6% | -$20M | $-999999.00 | -193.7% | -173.2% |
See PSTV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PSTV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PSTV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPSTV — Frequently Asked Questions
Quick answers to the most common questions about buying PSTV stock.
Is PSTV growing earnings?
PSTV EPS is $-7.19, with earnings growth accelerating to +100.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-22M.
What are PSTV's profit margins?
Plus Therapeutics, Inc. net margin is -429.4%, with operating margin at -293.5%. Below-average margins reflect competitive or cost pressures.
How consistent are PSTV's earnings?
PSTV earnings data spans 1998-2025. The accelerating earnings trend is +100.0% YoY. Historical data enables comparison across business cycles.